Report date: Nov 6,2024
Conflict count: 361874
Publisher: Fund Doctors, Innovations, Science for Children
Title count: 1
Conflict count: 3


==========================================================

Created: 2023-05-24 09:39:09
ConfID: 6852592
CauseID: 1574193254
OtherID: 1544890301
JT: Pediatric Hematology/Oncology and Immunopathology
MD: Lavrentyeva,21,3,115,2022,Laparoscopic appendectomy in a child with hemophilia A with inhibitors receiving prophylactic treatment with emicizumab
DOI: 10.24287/1726-1708-2022-21-3-115-11(Journal) (6852592-N)
DOI: 10.24287/1726-1708-2022-21-3-115-118(Journal)
==========================================================

Created: 2018-04-04 02:32:29
ConfID: 5355372
CauseID: 1424090723
OtherID: 1407239702
JT: Pediatric Hematology/Oncology and Immunopathology
MD: Goronkova,16,2,17,2017,The use of eltrombopag in children and young adults with acquired aplastic anemia
DOI: 10.24287/1726-1708-16-2-17-25(Journal) (5355372-N)
DOI: 10.24287/1726-1708-2017-16-2-17-25(Journal)
==========================================================

Created: 2018-04-04 03:47:58
ConfID: 5355375
CauseID: 1424095336
OtherID: 1407239702
JT: Pediatric Hematology/Oncology and Immunopathology
MD: Rumyantsev,16,2,62,2017,Prospects of targeted therapy of acute leukemias in children
DOI: 10.24287/1726-1708-16-2-62-74(Journal) (5355375-N)
DOI: 10.24287/1726-1708-2017-16-2-62-74(Journal)